Tilray (TLRY)
NASDAQ:TLRY
Want to see TLRY full AI Analyst Report?
TLRY Stock Chart & Stats
$6.86
-$0.07(-5.17%)
At close: 4:00 PM EST
$6.86
-$0.07(-5.17%)
Day’s Range― - ―
52-Week Range$3.50 - $23.20
Previous CloseN/A
Volume22.72M
Average Volume (3M)2.67M
Market Cap
$705.66M
Enterprise Value$801.38M
Total Cash (Recent Filing)$219.93M
Total Debt (Recent Filing)$317.08M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Jul 29, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-18.61
Shares Outstanding119,604,225
10 Day Avg. Volume2,796,034
30 Day Avg. Volume2,674,396
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.18
Price to Sales (P/S)0.34
P/FCF Ratio-2.17
Enterprise Value/Market Cap1.14
Enterprise Value/Revenue0.68
Enterprise Value/Gross Profit2.45
Enterprise Value/Ebitda-0.43
Forecast
1Y Price Target
$8.00Price Target Upside16.58% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering5
EPS Forecast (FY)-0.62
Revenue Forecast (FY)$881.00M
Bulls Say, Bears Say
Bulls Say
Financing AdvantageLower cost of capital due to being cash-flow positive and listed on a U.S. exchange provides access to cheaper funding, enabling investment in capacity and strategic initiatives.
International ExpansionExpansion of international operations supported by additional cultivation capacity in Canada and Portugal and rising medical cannabis demand in markets like Germany, which can drive increased exports and local sales.
Pharmaceutical Segment GrowthCC Pharma's accelerating growth, improving margins, and expanding relationships with pharmacies and pharmaceutical companies position the business to capture higher-margin medical and wellness revenue.
Bears Say
Acquisition Integration RiskA history of growth through acquisitions has created integration and operational challenges, and the acquired beer business's prior losses raise concerns about the ability to restore sustainable profitability.
Beverage Margin PressureBeverage gross margins are under pressure from volume declines tied to product lineup rationalization and loss of shelf space, combined with rising aluminum costs that reduce segment profitability.
Supply Chain And Input RiskHigh exposure to aluminum for canned products and the risk of supply disruptions linked to geopolitical conflict increase the likelihood of higher input costs and unstable raw material supply.
Tilray News
TLRY FAQ
What was Tilray’s price range in the past 12 months?
Tilray lowest stock price was $3.50 and its highest was $23.20 in the past 12 months.
What is Tilray’s market cap?
Tilray’s market cap is $705.66M.
When is Tilray’s upcoming earnings report date?
Tilray’s upcoming earnings report date is Jul 29, 2026 which is in 83 days.
How were Tilray’s earnings last quarter?
Tilray released its earnings results on Apr 01, 2026. The company reported -$0.224 earnings per share for the quarter, missing the consensus estimate of -$0.136 by -$0.088.
Is Tilray overvalued?
According to Wall Street analysts Tilray’s price is currently Undervalued.
Does Tilray pay dividends?
Tilray does not currently pay dividends.
What is Tilray’s EPS estimate?
Tilray’s EPS estimate is >-0.01.
How many shares outstanding does Tilray have?
Tilray has 119,604,225 shares outstanding.
What happened to Tilray’s price movement after its last earnings report?
Tilray reported an EPS of -$0.224 in its last earnings report, missing expectations of -$0.136. Following the earnings report the stock price went down -5.1%.
Which hedge fund is a major shareholder of Tilray?
Currently, no hedge funds are holding shares in TLRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tilray Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (16.58% Upside)
$8.00 (16.58% Upside)
Blogger Sentiment
Neutral
TLRY Sentiment 57%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 359.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $232.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
52.44%
12-Months-Change
Fundamentals
Return on Equity
-92.82%
Trailing 12-Months
Asset Growth
-39.04%
Trailing 12-Months
Company Description
Tilray
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
TLRY Earnings Call
Q3 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted clear operational progress: record quarterly revenue, strong international cannabis momentum, meaningful distribution growth, completed cost-savings programs and strategic beverage partnerships/acquisition that materially expand the company’s scale. Several significant challenges remain — beverage revenue and margin pressure, input cost volatility (aluminum, fuel), working capital-related cash use, regulatory uncertainty in the U.S., and integration work for BrewDog — but management presented concrete actions (hedging, Project 420, SKU rationalization, partnerships) and a strengthened liquidity position. On balance, the positive operational and strategic developments outweigh the near-term headwinds.View all TLRY earnings summariesTLRY Stock 12 Month Forecast
Average Price Target
$8.00
▲(16.58% Upside)
Technical Analysis
Ownership Overview
6.79% Insiders
0.41% Mutual Funds
0.26% Other Institutional Investors
89.34% Public Companies and Individual Investors